tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

SEPN Stock Latest News

Septerna: Advancing GPCR Pipeline and De-Risked Valuation Support Upgraded Buy Rating and $35 Target
RatingsSepterna: Advancing GPCR Pipeline and De-Risked Valuation Support Upgraded Buy Rating and $35 Target
17d ago
SEPN
Septerna price target raised to $35 from $30 at H.C. Wainwright
PremiumThe Fly
Septerna price target raised to $35 from $30 at H.C. Wainwright
17d ago
SEPN
Septerna to Present GPCR Pipeline Updates at JPM Conference
PremiumCompany Announcements
Septerna to Present GPCR Pipeline Updates at JPM Conference
25d ago
8K
SEPN
Septerna Appoints Mark Wilson as Chief Legal Officer
PremiumCompany Announcements
Septerna Appoints Mark Wilson as Chief Legal Officer
29d ago
8K
SEPN
Septerna appoints Mark Wilson as chief legal officer
PremiumThe Fly
Septerna appoints Mark Wilson as chief legal officer
29d ago
NKTR
SEPN
Coty downgraded, Spruce Biosciences initiated: Wall Street’s top analyst calls
PremiumThe FlyCoty downgraded, Spruce Biosciences initiated: Wall Street’s top analyst calls
1M ago
BC
AME
Septerna initiated with a Buy at JonesResearch
Premium
The Fly
Septerna initiated with a Buy at JonesResearch
2M ago
SEPN
Septerna initiated with a Strong Buy at Raymond James
Premium
The Fly
Septerna initiated with a Strong Buy at Raymond James
2M ago
SEPN
Septerna initiated with a Buy at Truist
PremiumThe Fly
Septerna initiated with a Buy at Truist
2M ago
SEPN
Septerna price target raised to $34 from $28 at JPMorgan
PremiumThe Fly
Septerna price target raised to $34 from $28 at JPMorgan
3M ago
SEPN
SEPN Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
SEPN Upcoming Earnings Report: What to Expect?
3M ago
SEPN
Wells upgrades Septerna to Overweight on 2026 share catalysts
PremiumThe Fly
Wells upgrades Septerna to Overweight on 2026 share catalysts
3M ago
SEPN
Septerna upgraded to Overweight from Equal Weight at Wells Fargo
PremiumThe FlySepterna upgraded to Overweight from Equal Weight at Wells Fargo
3M ago
SEPN
Septerna price target raised to $30 from $26 at H.C. Wainwright
Premium
The Fly
Septerna price target raised to $30 from $26 at H.C. Wainwright
3M ago
SEPN
Septerna reports Q3 EPS 18c, consensus 79c
Premium
The Fly
Septerna reports Q3 EPS 18c, consensus 79c
3M ago
SEPN
Septerna’s SEP-631 Study: A Potential Game-Changer in Pharmaceutical Research
PremiumCompany Announcements
Septerna’s SEP-631 Study: A Potential Game-Changer in Pharmaceutical Research
3M ago
SEPN
Septerna, Inc. Expands Board with New R&D Chair
PremiumCompany Announcements
Septerna, Inc. Expands Board with New R&D Chair
4M ago
8K
SEPN
Septerna Updates Presentation on Drug Discovery Progress
PremiumCompany Announcements
Septerna Updates Presentation on Drug Discovery Progress
5M ago
8K
SEPN
Septerna, Inc.: Advancements in Clinical Trials and Strategic Focus Drive Buy Rating
PremiumRatings
Septerna, Inc.: Advancements in Clinical Trials and Strategic Focus Drive Buy Rating
6M ago
SEPN
Septerna Begins Phase 1 Trial for SEP-631
PremiumCompany AnnouncementsSepterna Begins Phase 1 Trial for SEP-631
6M ago
8K
SEPN
Septerna doses first participants in Phase 1 trial of SEP-631
Premium
The Fly
Septerna doses first participants in Phase 1 trial of SEP-631
6M ago
SEPN
Septerna Reports Q2 2025 Financial Results and Progress
Premium
Company Announcements
Septerna Reports Q2 2025 Financial Results and Progress
6M ago
SEPN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >